Kumar AS - Search Results

1

A call for clinical trials: lipophilic statins may prove effective in treatment and prevention of particular breast cancer subtypes.

Kumar AS, Campbell M, Benz CC, Esserman LJ. Kumar AS, et al. J Clin Oncol. 2006 May 1;24(13):2127; author reply 2127-8. doi: 10.1200/JCO.2005.04.9882. J Clin Oncol. 2006. PMID: 16648516 No abstract available.

2

Clinical trials are required to prove the chemopreventive worth of statins.

Kumar AS, Benz CC, Esserman LJ. Kumar AS, et al. Arch Intern Med. 2006 May 22;166(10):1143; author reply 1144. doi: 10.1001/archinte.166.10.1143-a. Arch Intern Med. 2006. PMID: 16717179 No abstract available.

3

Statins: health-promoting agents show promise for breast cancer prevention.

Kumar AS, Esserman LJ. Kumar AS, et al. Clin Breast Cancer. 2005 Dec;6(5):455-9. doi: 10.3816/CBC.2005.n.051. Clin Breast Cancer. 2005. PMID: 16381630 Review. No abstract available.

4

Breast cancer growth prevention by statins.

Campbell MJ, Esserman LJ, Zhou Y, Shoemaker M, Lobo M, Borman E, Baehner F, Kumar AS, Adduci K, Marx C, Petricoin EF, Liotta LA, Winters M, Benz S, Benz CC. Campbell MJ, et al. Among authors: kumar as. Cancer Res. 2006 Sep 1;66(17):8707-14. doi: 10.1158/0008-5472.CAN-05-4061. Cancer Res. 2006. PMID: 16951186

5

Estrogen receptor-negative breast cancer is less likely to arise among lipophilic statin users.

Kumar AS, Benz CC, Shim V, Minami CA, Moore DH, Esserman LJ. Kumar AS, et al. Cancer Epidemiol Biomarkers Prev. 2008 May;17(5):1028-33. doi: 10.1158/1055-9965.EPI-07-0726. Epub 2008 May 7. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18463402

6

Magnetic resonance imaging captures the biology of ductal carcinoma in situ.

Esserman LJ, Kumar AS, Herrera AF, Leung J, Au A, Chen YY, Moore DH, Chen DF, Hellawell J, Wolverton D, Hwang ES, Hylton NM. Esserman LJ, et al. Among authors: kumar as. J Clin Oncol. 2006 Oct 1;24(28):4603-10. doi: 10.1200/JCO.2005.04.5518. J Clin Oncol. 2006. PMID: 17008702 Free PMC article.

7

Type and duration of exogenous hormone use affects breast cancer histology.

Kumar AS, Cureton E, Shim V, Sakata T, Moore DH, Benz CC, Esserman LJ, Hwang ES. Kumar AS, et al. Ann Surg Oncol. 2007 Feb;14(2):695-703. doi: 10.1245/s10434-006-9129-2. Epub 2006 Nov 14. Ann Surg Oncol. 2007. PMID: 17103262

8

Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer.

Garwood ER, Kumar AS, Baehner FL, Moore DH, Au A, Hylton N, Flowers CI, Garber J, Lesnikoski BA, Hwang ES, Olopade O, Port ER, Campbell M, Esserman LJ. Garwood ER, et al. Among authors: kumar as. Breast Cancer Res Treat. 2010 Jan;119(1):137-44. doi: 10.1007/s10549-009-0507-x. Breast Cancer Res Treat. 2010. PMID: 19728082 Free PMC article. Clinical Trial.

9

Biologic significance of false-positive magnetic resonance imaging enhancement in the setting of ductal carcinoma in situ.

Kumar AS, Chen DF, Au A, Chen YY, Leung J, Garwood ER, Gibbs J, Hylton N, Esserman LJ. Kumar AS, et al. Am J Surg. 2006 Oct;192(4):520-4. doi: 10.1016/j.amjsurg.2006.07.003. Am J Surg. 2006. PMID: 16978965 Free PMC article.

10

Optimizing the total skin-sparing mastectomy.

Wijayanayagam A, Kumar AS, Foster RD, Esserman LJ. Wijayanayagam A, et al. Among authors: kumar as. Arch Surg. 2008 Jan;143(1):38-45; discussion 45. doi: 10.1001/archsurg.143.1.38. Arch Surg. 2008. PMID: 18209151

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

545 results

Search Page

Filters